Featured Article
DaVita, a kidney care provider primarily serving the United States, had a positive FY 2024. Revenue rose 5.6% to $12.8 billion, and operating profits rose 30% to $2.1 billion over last year. A review of DaVita’s 13 February 2025 earnings call and associated financial reports provided insight regarding the importance of pricing on performance. FACTS FROM EARNINGS CALL AND ANNUAL REPORT Javier Rodriguez, CEO of DaVita, sent mixed signals about revenue drivers.…
In This Issue
Nordson, a precision technology company for dispensing fluids, had a positive FY 2025. Revenue rose 3.8% to $2.8 billion and operating income…
NIKE, an athletic footwear, apparel, and equipment company selling NIKE, Jordan, and Converse brands, had a negative FY 2025. Revenue fell 9.8%…
Allegion, a global provider of branded security products, had a positive FY 2024. Revenue rose 3.3% to $3.8 billion and earnings before…
Quest Diagnostics, a U.S. healthcare diagnostic company, had a positive FY 2024. Revenue rose 6.7% to $9.87 billion, and earnings before interest…